Form 4 Filing for CollPlant Biotechnologies Ltd

This filing details the beneficial ownership of Hugh M Evans, a director at CollPlant Biotechnologies Ltd. Evans directly owns 10,000 Restricted Share Units (RSUs), with 3,125 vested and the remainder vesting quarterly until September 2028. He also directly holds 315,554 ordinary shares. Additionally, Evans holds exercisable options to purchase 23,000 ordinary shares with an exercise price of $6.39, expiring in May 2031, and another 24,000 options with the same exercise price, vesting on May 2, 2026. Indirectly, he holds 10,000 ordinary shares through his spouse and 15,000 ordinary shares via a trust for his children, where he serves as a trustee but disclaims beneficial ownership.